Arthur Marie Joseph Ghislain Deboeck - Net Worth and Insider Trading
Arthur Marie Joseph Ghislain Deboeck Net Worth
The estimated net worth of Arthur Marie Joseph Ghislain Deboeck is at least $4 Million dollars as of 2024-09-24. Arthur Marie Joseph Ghislain Deboeck is the Director of Cipher Pharmaceuticals Inc and owns about 244,562 shares of Cipher Pharmaceuticals Inc (TSX:CPH) stock worth over $4 Million. Details can be seen in Arthur Marie Joseph Ghislain Deboeck's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Arthur Marie Joseph Ghislain Deboeck has not made any transactions after 2019-08-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Arthur Marie Joseph Ghislain Deboeck
Arthur Marie Joseph Ghislain Deboeck Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Arthur Marie Joseph Ghislain Deboeck owns 1 companies in total, including Cipher Pharmaceuticals Inc (TSX:CPH) .
Insider Ownership Summary of Arthur Marie Joseph Ghislain Deboeck
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TSX:CPH | Cipher Pharmaceuticals Inc | 2019-08-22 | Director |
Arthur Marie Joseph Ghislain Deboeck Latest Holdings Summary
Arthur Marie Joseph Ghislain Deboeck currently owns a total of 1 stock. Arthur Marie Joseph Ghislain Deboeck owns 244,562 shares of Cipher Pharmaceuticals Inc (TSX:CPH) as of August 22, 2019, with a value of $4 Million.
Latest Holdings of Arthur Marie Joseph Ghislain Deboeck
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TSX:CPH | Cipher Pharmaceuticals Inc | 2019-08-22 | 244,562 | 14.79 | 3,617,072 |
Holding Weightings of Arthur Marie Joseph Ghislain Deboeck
Arthur Marie Joseph Ghislain Deboeck Form 4 Trading Tracker
According to the SEC Form 4 filings, Arthur Marie Joseph Ghislain Deboeck has made a total of 0 transactions in Cipher Pharmaceuticals Inc (TSX:CPH) over the past 5 years. The most-recent trade in Cipher Pharmaceuticals Inc is the acquisition of 24,800 shares on August 22, 2019, which cost Arthur Marie Joseph Ghislain Deboeck around $32,372.
Insider Trading History of Arthur Marie Joseph Ghislain Deboeck
- 1
Arthur Marie Joseph Ghislain Deboeck Trading Performance
GuruFocus tracks the stock performance after each of Arthur Marie Joseph Ghislain Deboeck's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Arthur Marie Joseph Ghislain Deboeck is -4.75%. GuruFocus also compares Arthur Marie Joseph Ghislain Deboeck's trading performance to market benchmark return within the same time period. The performance of stocks bought by Arthur Marie Joseph Ghislain Deboeck within 3 months outperforms 0 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Arthur Marie Joseph Ghislain Deboeck's insider trading performs compared to the benchmark.
Performance of Arthur Marie Joseph Ghislain Deboeck
Arthur Marie Joseph Ghislain Deboeck Ownership Network
Arthur Marie Joseph Ghislain Deboeck Owned Company Details
What does Cipher Pharmaceuticals Inc do?
Who are the key executives at Cipher Pharmaceuticals Inc?
Arthur Marie Joseph Ghislain Deboeck is the Director of Cipher Pharmaceuticals Inc. Other key executives at Cipher Pharmaceuticals Inc include Senior Officer Bryan Jacobs , Senior Officer Scott Langille , and Senior Officer Nadine Jutlah .
Cipher Pharmaceuticals Inc (TSX:CPH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cipher Pharmaceuticals Inc (TSX:CPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cipher Pharmaceuticals Inc (TSX:CPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cipher Pharmaceuticals Inc (TSX:CPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cipher Pharmaceuticals Inc Insider Transactions
Arthur Marie Joseph Ghislain Deboeck Mailing Address
Above is the net worth, insider trading, and ownership report for Arthur Marie Joseph Ghislain Deboeck. Currently GuruFocus does not have mailing address information for Arthur Marie Joseph Ghislain Deboeck.